Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia.
about
Cannabis and psychosis/schizophrenia: human studiesEmerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders.Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder.Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatmentDevelopmental vitamin D deficiency and schizophrenia: the role of animal models.Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Behavioral and molecular evidence for psychotropic effects in L-theanine.TrkB interacts with ErbB4 and regulates NRG1-induced NR2B phosphorylation in cortical neurons before synaptogenesis.Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo.Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndromePharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.Brain-derived neurotrophic factor and neuropsychiatric disorders.Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation.BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.BDNF-TrkB signaling and neuroprotection in schizophreniaAssociations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels.Antioxidants as potential therapeutics for neuropsychiatric disorders.Gene therapy in Alzheimer's disease - potential for disease modificationBrain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomesPreliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humansNeurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury.Glucocorticoid regulates TrkB protein levels via c-Cbl dependent ubiquitination: a decrease in c-Cbl mRNA in the prefrontal cortex of suicide subjects.Influence of brain-derived neurotrophic factor on pathfinding of dentate granule cell axons, the hippocampal mossy fibers.Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status.Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.Glioma in Schizophrenia: Is the Risk Higher or Lower?
P2860
Q24628837-115385C4-6624-4F72-A64B-D87E1E82617CQ27333743-B8D5CF42-91E4-401A-9EF5-FA7783AEA79CQ27335060-1C6AD1C6-21C6-4F22-844E-6BC84927B529Q28477574-AA0855BC-3E59-4AFF-8E58-C5614448760DQ30366744-84E18789-EB8B-4647-960A-4CAEE33E5AF9Q30416883-8506C066-4297-481F-8C10-660D85BBCAD8Q34210127-829B7ACB-160D-460A-A5B6-B34EAD3A0A23Q34468984-ECF90667-76A7-49B3-8083-B735BC84AD14Q34731431-4086CDAC-5902-461C-BA6D-D6A8A79F0DCBQ35054548-642C1A34-A0CA-46AA-A6B6-B0E11FC952B8Q35179012-A39C761E-5285-4DAD-A5C8-F99ED56BD638Q35284133-536E1009-544C-4E8E-9C55-4E4855E5973FQ35760210-CA5CE64B-AF26-4FB9-9FB6-9E2A530506F8Q35847085-6E201366-FC78-4798-921C-50D2AF61B980Q36113520-F059D84F-4D87-4F33-9AAB-A7E6294FD99DQ36377832-CD776CF4-824E-4D70-9185-682369E4871BQ36589545-6E8392BF-F53F-47D6-8C49-5FCE6EBC40EDQ36591204-1F3B8A34-BB49-49CC-A6DF-D5248D347E06Q36736055-D6F443DD-CA1B-4D1C-A54C-3B18514730A1Q37295252-6AC68869-2123-4BB4-A430-2E42CB800AFFQ37328165-E2C4AEBB-5AF0-430C-91BB-C7706971E460Q37470412-AA068908-E718-41AE-8074-0EB01546856AQ38125218-16C42A4F-8F47-407B-8491-0DBDE1649AF9Q38168376-E0321BF9-7E25-4E85-BCCA-5A4D3BF594A6Q38587566-F9E63F5C-36DB-414A-816C-FBDBFE6DF1B3Q39157121-15AA4239-5224-43D6-ADAA-9C1EAF9AC7B1Q42751211-01E4103E-D2B2-420E-A393-5F353CCF1E92Q43180712-068BFDFD-F159-47A5-8F2F-B3C4BEDC65D9Q47778933-783BC7A8-B5DF-4520-81C4-8DDC229515ABQ48397485-FA0A7748-596E-4D10-AF9A-2471FC800482Q48582684-A6128A66-6550-4BC1-A787-ECB18EF6E84DQ58767549-893AE368-0828-4A8B-B4E7-E313C0161880
P2860
Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@en
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@nl
type
label
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@en
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@nl
prefLabel
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@en
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@nl
P2860
P921
P356
P1433
P1476
Brain-derived neurotropic fact ...... rmacotherapy of schizophrenia.
@en
P2093
Anilkumar Pillai
P2860
P304
P356
10.1159/000111562
P577
2008-02-05T00:00:00Z